ANTRESA WEATHERSBY: Open Payments
NPI 1750683264 · CEDAR HILL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 21 payments from 9 companies in 2025. Trend: 2023 $616 · 2024 $656 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $146 |
| Lilly USA, LLC | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| PFIZER INC. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, JARDIANCE, MOUNJARO, AIRSUPRA, GEMTESA, PREVNAR 20, Ozempic, Symbravo.
Industry payments across TX — which companies pay providers there.
